References: Antibiotic management of bronchiectasis in adults
Chalmers JD, Boersma W, Lonergan M, Jayaram L, Crichton ML, Karalus N, et al. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Lancet Respir Med 2019;7(10):845-54. https://www.ncbi.nlm.nih.gov/pubmed/31405828
Chang AB, Bell SC, Byrnes CA, Dawkins P, Holland AE, Kennedy E, et al. Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand. Respirology 2023. https://www.ncbi.nlm.nih.gov/pubmed/36863703
Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc 2015;12(11):1602-11. https://pubmed.ncbi.nlm.nih.gov/26356317/
Gao YH, Guan WJ, Xu G, Lin ZY, Tang Y, Lin ZM, et al. The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study. Chest 2015;147(6):1635-43. https://pubmed.ncbi.nlm.nih.gov/25412225/
Haworth CS. RCT Abstract - The efficacy and safety of colistimethate sodium delivered via the I-neb in bronchiectasis: the PROMIS-I randomized controlled trial. European Respiratory Journal 2021;58(suppl 65). https://erj.ersjournals.com/content/58/suppl_65/RCT4267
Hill AT, Haworth CS, Aliberti S, Barker A, Blasi F, Boersma W, et al. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J 2017;49(6). https://www.ncbi.nlm.nih.gov/pubmed/28596426
Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax 2019;74(Suppl 1):1-69. https://www.ncbi.nlm.nih.gov/pubmed/30545985
Laska IF, Crichton ML, Shoemark A, Chalmers JD. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis. Lancet Respir Med 2019;7(10):855-69. https://www.ncbi.nlm.nih.gov/pubmed/31405826
Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017;50(3). https://www.ncbi.nlm.nih.gov/pubmed/28889110
Tejada S, Campogiani L, Sole-Lleonart C, Gomez A, Gallego M, Vendrell M, et al. Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Eur J Intern Med 2021;90:77-88. https://www.ncbi.nlm.nih.gov/pubmed/33947626
Wurzel D, Marchant JM, Yerkovich ST, Upham JW, Masters IB, Chang AB. Short courses of antibiotics for children and adults with bronchiectasis. Cochrane Database Syst Rev 2011;(6):CD008695. https://pubmed.ncbi.nlm.nih.gov/21678381/
